281 results on '"Goldberg, J. D."'
Search Results
2. S182: TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED EFFICACY AND SAFETY RESULTS FROM MONUMENTAL-1
3. S183: NOVEL COMBINATION IMMUNOTHERAPY FOR THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1B RESULTS FOR TALQUETAMAB (A GPRC5D X CD3 BISPECIFIC ANTIBODY) IN COMBINATION WITH DARATUMUMAB
4. Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts
5. Safety of voriconazole and sirolimus coadministration after allogeneic hematopoietic SCT
6. P10: TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED PHASE 1 RESULTS FROM MONUMENTAL-1
7. A novel reduced intensity conditioning regimen for patients with high-risk hematological malignancies undergoing allogeneic stem cell transplantation
8. Structure and function of the serine pathway enzymes in Hyphomicrobium
9. The Estimation of False Negatives in Medical Screening
10. Conventional X-Ray Diffraction Approaches to the Study of Enzyme Mechanism: Serine Proteinases, Aminoacyl-tRNA Synthetases and Xylose Isomerase
11. Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants
12. Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT
13. Multilocus genetic analysis of single interphase cells by spectral imaging
14. Intravoxel Incoherent Motion Imaging of Tumor Microenvironment in Locally Advanced Breast Cancer
15. Recombinant human interleukin-7 (CYT107) enhances T-cell recovery without causing graft-versus-host disease following T-cell depleted allogeneic haematopoietic stem cell transplantation: O183
16. KGF decreases mucositis severity in recipients of TBI-based but not chemotherapy-based allogeneic haematopoietic stem cell transplants: O177
17. Establishing a Research Tissue Bank (TB): The Myeloproliferative Disorders Research Consortium (MPD-RC) Experience: SP439
18. ‘Kennel Cough’ in a patient following allogeneic hematopoietic stem cell transplant
19. Unreliability of platelet glucose-6-phosphatase for the diagnosis of glycogen storage disease type Ia
20. Prenatal diagnosis and characterization of an unbalanced whole arm translocation resulting in monosomy for 18p
21. Pränatale Diagnostik im 1. Trimenon: Anwendung bei genetisch bedingten Stoffwechselstörungen
22. First Trimester Fetal Diagnosis: Principles and Potential Pitfalls in Enzymatic and Molecular Diagnoses
23. Single-item migraine screening tests, self-reported bothersome headache or stripe pattern hypersensitivity?
24. Cis-Platinum Trials for Gynecological Tumors
25. Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas
26. Single agent bevacizumab for myelofibrosis: results of the Myeloproliferative Disorders Research Consortium Trial
27. Single-item migraine screening tests, self-reported bothersome headache or stripe pattern hypersensitivity?
28. Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants
29. Impact of population genetic substructure on association studies and risk assessment for melanoma.
30. A population-based, case-control study of MC1R variants, ultraviolet light exposure, and melanoma.
31. Prevention of mucositis with KGF in patients undergoing allogeneic stem cell transplantation.
32. Impact of socioeconomic status on melanoma clinical presentation and prognosis in non-White melanoma patients.
33. Predictors of pathologic response and correlation with long-term outcomes in a trial of neoadjuvant concurrent paclitaxel radiation in locally advanced breast cancer (LABC).
34. Five-year results of preoperative concurrent paclitaxel with radiation in locally advanced breast cancer (LABC).
35. Identification of tyrosinase polymorphisms for use in melanoma risk assessment.
36. Evaluation of toll-like receptor (TLR)-7 agonist imiquimod applied topically to breast cancer chest wall recurrences or skin metastases.
37. Prenatal diagnosis of inherited metabolic diseases
38. Neoadjuvant therapy of gastric cancer with cetuximab added to both irinotecan and cisplatin, followed by surgical resection and adjuvant chemoradiation
39. Evaluation of the melanocortin-1-receptor gene in melanoma predisposition, progression, and recurrence
40. Developing genetic markers for melanoma risk assessment
41. Comparison of the immunogenicity of Montanide ISA 51 adjuvant and cytokine-matured dendritic cells in a randomized controlled clinical trial of melanoma vaccines
42. Effect of mebendazole on melanoma xenograft growth through targeting of bcl-2
43. The genetic sonogram in screening for Down syndrome.
44. Who should be offered prenatal diagnosis? The 35-year-old question.
45. Second‐trimester ultrasound markers for the detection of Down's syndrome: are they worth the effort?
46. Meta-analysis: An introduction and point of view
47. Teratogen Exposure
48. Teratogen exposure: lack of morphological abnormalities by detailed fetal sonography
49. The preparation of a syllabus in social medicine: McKeown revisited.
50. Growth retardation in prenatally diagnosed cases of gastroschisis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.